Clinical Trials Directory

Trials / Conditions / Recurrent Wilms Tumor and Other Childhood Kidney Tumors

Recurrent Wilms Tumor and Other Childhood Kidney Tumors

13 registered clinical trials studyying Recurrent Wilms Tumor and Other Childhood Kidney Tumors.

StatusTrialSponsorPhase
CompletedStudying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
NCT01614808
Children's Oncology Group—
CompletedSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liv
NCT01502410
National Cancer Institute (NCI)Phase 2
CompletedSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or
NCT01305200
Children's Oncology GroupPhase 3
CompletedIntensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
NCT01586104
Ann & Robert H Lurie Children's Hospital of ChicagoN/A
CompletedBiomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
NCT01118078
Children's Oncology Group—
CompletedCixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00831844
National Cancer Institute (NCI)Phase 2
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem
NCT00408681
Fred Hutchinson Cancer CenterN/A
CompletedIxabepilone in Treating Young Patients With Refractory Solid Tumors
NCT00331643
National Cancer Institute (NCI)Phase 2
CompletedEtanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Tr
NCT00309907
Children's Oncology GroupPhase 2
CompletedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
National Cancer Institute (NCI)Phase 1
CompletedGene Expression Profiles to Categorize Wilms Tumors
NCT00897637
Children's Oncology Group—
CompletedFlavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NCT00012181
National Cancer Institute (NCI)Phase 1